Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

14.07 -1.29 (-8.43%)
Streaming Delayed Price Updated: 3:54 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,092,479
Open 14.89
Bid (Size) 14.07 (2,800)
Ask (Size) 14.08 (1,700)
Prev. Close 15.37
Today's Range 13.83 - 15.24
52wk Range 13.50 - 25.67
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For November 5, 2025
 
Via Benzinga

Performance

YTD
-21.7%
-21.7%
1 Month
+0.0%
+0.0%
3 Month
-24.2%
-24.2%
6 Month
-40.4%
-40.4%
1 Year
-25.3%
-25.3%

More News

Read More
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
Via The Motley Fool
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
Via Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
Via Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
Via Benzinga
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Via Benzinga
How Is The Market Feeling About ADMA Biologics?
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
ADMA Biologics Earnings Preview
Via Benzinga
Adma Biologics (ADMA) Q2 Revenue Up 14%
Via The Motley Fool
Topics Economy
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria
Via Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup
Via Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock
Via Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing.
Via Chartmill
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
Via Benzinga
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits
Via Investor's Business Daily
Topics Earnings
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
3 Mid-Cap Medical Stocks Outperforming the Market
Via MarketBeat
Topics Economy

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?
Yes, ADMA Biologics Inc - Common Stock is publicly traded.
What exchange does ADMA Biologics Inc - Common Stock trade on?
ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ADMA Biologics Inc - Common Stock?
The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
What is the current price of ADMA Biologics Inc - Common Stock?
The current price of ADMA Biologics Inc - Common Stock is 14.07
When was ADMA Biologics Inc - Common Stock last traded?
The last trade of ADMA Biologics Inc - Common Stock was at 11/06/25 03:54 PM ET
What is the market capitalization of ADMA Biologics Inc - Common Stock?
The market capitalization of ADMA Biologics Inc - Common Stock is 2.76B
How many shares of ADMA Biologics Inc - Common Stock are outstanding?
ADMA Biologics Inc - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.